Stockreport

Galera Therapeutics Announces Pricing of Initial Public Offering

Galera Therapeutics, Inc.  (GRTX) 
PDF MALVERN, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commerci [Read more]